Literature DB >> 28705515

Combination vaccine strategies to prevent enteric infections.

Richard Walker1, Peter Dull2.   

Abstract

New vaccine candidates entering the current routine immunization schedule can best be accommodated as combination vaccines. A combined Shigella and enterotoxigenic E. coli (ETEC) vaccine could greatly benefit children in disease-endemic areas. New candidates are getting closer to being able to meet these needs, but they raise numerous strategic questions related to presentation, formulation, and regulatory approach. The "Combination Vaccine Strategies to Prevent Enteric Infections" workshop at the 2016 Vaccines Against Shigella and ETEC (VASE) Conference examined some of the considerations for developing such vaccines against enteric pathogens.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Combined vaccines; ETEC; Enterotoxigenic Escherichia coli; Regulatory strategy; Shigella

Mesh:

Substances:

Year:  2017        PMID: 28705515     DOI: 10.1016/j.vaccine.2017.06.076

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

Review 1.  Enterotoxigenic Escherichia coli Infections.

Authors:  James M Fleckenstein; F Matthew Kuhlmann
Journal:  Curr Infect Dis Rep       Date:  2019-03-04       Impact factor: 3.725

2.  Vaccines against gastroenteritis, current progress and challenges.

Authors:  Hyesuk Seo; Qiangde Duan; Weiping Zhang
Journal:  Gut Microbes       Date:  2020-06-18

3.  Preclinical Characterization of Immunogenicity and Efficacy against Diarrhea from MecVax, a Multivalent Enterotoxigenic E. coli Vaccine Candidate.

Authors:  Hyesuk Seo; Carolina Garcia; Xiaosai Ruan; Qiangde Duan; David A Sack; Weiping Zhang
Journal:  Infect Immun       Date:  2021-06-16       Impact factor: 3.441

Review 4.  Enterotoxigenic Escherichia coli (ETEC) vaccines: Priority activities to enable product development, licensure, and global access.

Authors:  Ibrahim Khalil; Richard Walker; Chad K Porter; Farzana Muhib; Roma Chilengi; Alejandro Cravioto; Richard Guerrant; Ann-Mari Svennerholm; Firdausi Qadri; Shahida Baqar; Margaret Kosek; Gagandeep Kang; Claudio Lanata; George Armah; Thomas Wierzba; Mateusz Hasso-Agopsowicz; Birgitte Giersing; A Louis Bourgeois
Journal:  Vaccine       Date:  2021-05-06       Impact factor: 3.641

5.  A bivalent vaccine confers immunogenicity and protection against Shigella flexneri and enterotoxigenic Escherichia coli infections in mice.

Authors:  Pedro Henrique Q S Medeiros; David T Bolick; Solanka E Ledwaba; Glynis L Kolling; Deiziane V S Costa; Reinaldo B Oriá; Aldo Ângelo M Lima; Eileen M Barry; Richard L Guerrant
Journal:  NPJ Vaccines       Date:  2020-03-27       Impact factor: 7.344

6.  Safety and immunogenicity of intramuscularly administered CS6 subunit vaccine with a modified heat-labile enterotoxin from enterotoxigenic Escherichia coli.

Authors:  Tida Lee; Ramiro L Gutiérrez; Milton Maciel; Steven Poole; Kayla J Testa; Stefanie Trop; Christopher Duplessis; Alison Lane; Mark S Riddle; Melinda Hamer; Ashley Alcala; Michael Prouty; Nicole Maier; Rahsan Erdem; A Louis Bourgeois; Chad K Porter
Journal:  Vaccine       Date:  2021-08-18       Impact factor: 3.641

Review 7.  Vaccines for Protecting Infants from Bacterial Causes of Diarrheal Disease.

Authors:  Richard Walker; Robert W Kaminski; Chad Porter; Robert K M Choy; Jessica A White; James M Fleckenstein; Fred Cassels; Louis Bourgeois
Journal:  Microorganisms       Date:  2021-06-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.